Variant report

Variant	esv1807897
Chromosome Location	chr19:43614685-43801559
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:2540)
CpG islands
(count:1284)
Chromatin interactive
region (count:2)
LncRNA
region (count:31)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:2540 , 50 per page) page: 1 2 3 4 5 6 7 ... 51

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr19:43779068-43779071	K562	blood:	n/a	n/a
2	ATF1	chr19:43733581-43733686	K562	blood:	n/a	n/a
3	ATF3	chr19:43686016-43686763	A549	lung:	n/a	n/a
4	BATF	chr19:43798559-43798850	GM12878	blood:	n/a	chr19:43798663-43798674
5	BATF	chr19:43692257-43692526	GM12878	blood:	n/a	n/a
6	BATF	chr19:43692397-43692675	GM12878	blood:	n/a	n/a
7	BATF	chr19:43738081-43738296	GM12878	blood:	n/a	chr19:43738185-43738196
8	BATF	chr19:43775309-43775522	GM12878	blood:	n/a	n/a
9	BATF	chr19:43711409-43711658	GM12878	blood:	n/a	n/a
10	BHLHE40	chr19:43709323-43709343	K562	blood:	n/a	n/a
11	BHLHE40	chr19:43733601-43733620	K562	blood:	n/a	n/a
12	BRCA1	chr19:43624776-43624937	Hela-S3	cervix:	n/a	n/a
13	BRCA1	chr19:43769426-43769782	Hela-S3	cervix:	n/a	n/a
14	CBX3	chr19:43775261-43775711	HCT-116	colon:	n/a	n/a
15	CBX3	chr19:43775276-43775644	K562	blood:	n/a	n/a
16	CEBPB	chr19:43675341-43675474	Hela-S3	cervix:	n/a	n/a
17	CEBPB	chr19:43685985-43686627	IMR90	lung:	n/a	n/a
18	CEBPB	chr19:43676596-43676779	K562	blood:	n/a	n/a
19	CEBPB	chr19:43705598-43705699	IMR90	lung:	n/a	n/a
20	CEBPB	chr19:43709791-43709942	Hela-S3	cervix:	n/a	n/a
21	CEBPB	chr19:43685962-43686735	A549	lung:	n/a	n/a
22	CEBPB	chr19:43790251-43790803	Hela-S3	cervix:	n/a	n/a
23	CEBPB	chr19:43759754-43759856	K562	blood:	n/a	n/a
24	CEBPB	chr19:43685985-43686805	Hela-S3	cervix:	n/a	n/a
25	CEBPB	chr19:43786125-43786327	Hela-S3	cervix:	n/a	n/a
26	CEBPB	chr19:43653804-43654163	IMR90	lung:	n/a	n/a
27	CEBPB	chr19:43705122-43705386	IMR90	lung:	n/a	n/a
28	CEBPB	chr19:43618826-43619087	IMR90	lung:	n/a	n/a
29	CEBPB	chr19:43656390-43656701	K562	blood:	n/a	chr19:43656521-43656532
30	CEBPB	chr19:43769050-43769817	Hela-S3	cervix:	n/a	n/a
31	CEBPB	chr19:43728619-43728662	Hela-S3	cervix:	n/a	n/a
32	CEBPB	chr19:43668229-43668245	IMR90	lung:	n/a	n/a
33	CEBPB	chr19:43768999-43769727	IMR90	lung:	n/a	n/a
34	CEBPB	chr19:43634604-43634632	HepG2	liver:	n/a	chr19:43634618-43634629 chr19:43634616-43634629 chr19:43634616-43634629 chr19:43634616-43634627
35	CEBPB	chr19:43656366-43656852	IMR90	lung:	n/a	chr19:43656521-43656532
36	CEBPB	chr19:43656430-43656683	A549	lung:	n/a	chr19:43656521-43656532
37	CEBPB	chr19:43686079-43686251	A549	lung:	n/a	n/a
38	CEBPB	chr19:43705107-43705824	Hela-S3	cervix:	n/a	n/a
39	CEBPB	chr19:43624758-43624915	Hela-S3	cervix:	n/a	n/a
40	CEBPB	chr19:43656448-43656689	HepG2	liver:	n/a	chr19:43656521-43656532
41	CEBPB	chr19:43656349-43656822	Hela-S3	cervix:	n/a	chr19:43656521-43656532
42	CEBPB	chr19:43686010-43686301	A549	lung:	n/a	n/a
43	CHD1	chr19:43778774-43779172	IMR90	lung:	n/a	n/a
44	CHD1	chr19:43624311-43625193	IMR90	lung:	n/a	n/a
45	CHD2	chr19:43624709-43625008	Hela-S3	cervix:	n/a	n/a
46	CHD2	chr19:43769435-43769730	Hela-S3	cervix:	n/a	n/a
47	CHD2	chr19:43790318-43790669	Hela-S3	cervix:	n/a	n/a
48	CTCF	chr19:43715060-43715210	GM06990	blood:	n/a	n/a
49	CTCF	chr19:43683920-43684070	GM12872	blood:	n/a	n/a
50	CTCF	chr19:43692308-43692481	GM19238	blood:	n/a	chr19:43692365-43692386 chr19:43692376-43692385 chr19:43692370-43692388

(count:1284 , 50 per page) page: 1 2 3 4 5 6 7 ... 26

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:43673501-43673551	BE2_C	brain:	n/a
2	chr19:43673501-43673551	AG10803	skin:	n/a
3	chr19:43711064-43711114	BE2_C	brain:	n/a
4	chr19:43673501-43673551	BE2_C	brain:	n/a
5	chr19:43673501-43673551	AG10803	skin:	n/a
6	chr19:43711064-43711114	BE2_C	brain:	n/a
7	chr19:43774982-43775032	NT2-D1	testis:	n/a
8	chr19:43673501-43673551	SK-N-MC	brain:	n/a
9	chr19:43773649-43773699	AG10803	skin:	n/a
10	chr19:43691930-43691980	AG09309	skin:	n/a
11	chr19:43691930-43691980	HCF	heart:	n/a
12	chr19:43690996-43691046	ProgFib	skin:	n/a
13	chr19:43774820-43774870	AG04449	skin:	fetal
14	chr19:43680072-43680122	ECC-1	luminal epithelium:	n/a
15	chr19:43774982-43775032	Jurkat	blood:	n/a
16	chr19:43774893-43774943	HRCEpiC	kidney:	n/a
17	chr19:43697480-43697530	GM06990	blood:	n/a
18	chr19:43680072-43680122	HEK293	kidney:	embryo
19	chr19:43690996-43691046	GM12892	blood:	n/a
20	chr19:43690622-43690672	HPAEpiC	pulmonary alveolar:	n/a
21	chr19:43691930-43691980	HUVEC	blood vessel:	n/a
22	chr19:43683698-43683748	BJ	skin:	n/a
23	chr19:43711249-43711299	HMEC	breast:	n/a
24	chr19:43680072-43680122	GM06990	blood:	n/a
25	chr19:43774893-43774943	Hela-S3	cervix:	n/a
26	chr19:43709654-43709704	U87	brain:	n/a
27	chr19:43680072-43680122	CMK	blood:	n/a
28	chr19:43709360-43709410	NH-A	brain:	n/a
29	chr19:43691930-43691980	A549	lung:	n/a
30	chr19:43673501-43673551	HRPEpiC	eye:	n/a
31	chr19:43690996-43691046	BE2_C	brain:	n/a
32	chr19:43711249-43711299	AG04449	skin:	fetal
33	chr19:43773649-43773699	H1-hESC	embryonic stem cell:	embryo
34	chr19:43774982-43775032	NH-A	brain:	n/a
35	chr19:43691878-43691928	BJ	skin:	n/a
36	chr19:43690996-43691046	HMEC	breast:	n/a
37	chr19:43711064-43711114	ProgFib	skin:	n/a
38	chr19:43673501-43673551	AG04450	lung:	fetal
39	chr19:43774820-43774870	ProgFib	skin:	n/a
40	chr19:43691878-43691928	ovcar-3	ovarian:	n/a
41	chr19:43680072-43680122	LNCaP	prostate:	n/a
42	chr19:43709832-43709882	GM12891	blood:	n/a
43	chr19:43769725-43769775	HNPCEpiC	eye:	n/a
44	chr19:43680072-43680122	HMEC	breast:	n/a
45	chr19:43697480-43697530	BJ	skin:	n/a
46	chr19:43690622-43690672	PANC-1	pancreas:	n/a
47	chr19:43690622-43690672	MCF-7	breast:	n/a
48	chr19:43774921-43774971	HEEpiC	esophagus:	n/a
49	chr19:43774921-43774971	A549	lung:	n/a
50	chr19:43709832-43709882	AG10803	skin:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr19:43678340..43681333-chr19:43698109..43700078,2	MCF-7	breast:
2	chr19:43265768..43266290-chr19:43769932..43770473,2	MCF-7	breast:

(count:31 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PSG9-2	chr19:43752643-43752798	NONHSAT066591
2	lnc-PSG9-2	chr19:43715943-43716627	NONHSAT066591
3	lnc-PSG9-2	chr19:43719405-43719531	NONHSAT066591
4	lnc-PSG4-2	chr19:43688934-43689087	NONHSAT066587
5	lnc-CD177-1	chr19:43657665-43657763	ENSG00000227606.1
6	lnc-PSG9-2	chr19:43752160-43752275	NONHSAT066591
7	lnc-PSG9-2	chr19:43762354-43762608	NONHSAT066592
8	lnc-PSG9-2	chr19:43727043-43727110	NONHSAT066591
9	lnc-PSG4-2	chr19:43684499-43684748	NONHSAT066587
10	lnc-PSG9-2	chr19:43734076-43734177	NONHSAT066591
11	lnc-PSG4-3	chr19:43674207-43674717	NONHSAT066586
12	lnc-CD177-1	chr19:43665002-43665014	ENSG00000227606.1
13	lnc-CD177-1	chr19:43658863-43659311	ENSG00000227606.1
14	lnc-PSG4-1	chr19:43707241-43708403	NONHSAT066590
15	lnc-PSG9-2	chr19:43763009-43764898	NONHSAT066592
16	lnc-PSG4-3	chr19:43672274-43672355	NONHSAT066586
17	lnc-PSG9-2	chr19:43728324-43728464	NONHSAT066591
18	lnc-CD177-1	chr19:43657431-43657763	ENSG00000227606.1
19	lnc-PSG5-1	chr19:43699147-43699301	NONHSAT066589
20	lnc-PSG5-1	chr19:43698107-43698746	NONHSAT066589
21	lnc-CD177-1	chr19:43659324-43659477	ENSG00000227606.1
22	lnc-PSG5-1	chr19:43698492-43699038	NONHSAT066588
23	lnc-PSG9-2	chr19:43724140-43724394	NONHSAT066593
24	lnc-PSG4-3	chr19:43674207-43674723	NONHSAT066585
25	lnc-PSG4-3	chr19:43671924-43672287	NONHSAT066585
26	lnc-PSG9-2	chr19:43737376-43737446	NONHSAT066591
27	lnc-PSG9-2	chr19:43715943-43716627	NONHSAT066592
28	lnc-PSG5-1	chr19:43696890-43697540	NONHSAT066588
29	lnc-PSG9-2	chr19:43724140-43724394	NONHSAT066591
30	lnc-PSG9-2	chr19:43724783-43725023	NONHSAT066593
31	lnc-PSG4-1	chr19:43710321-43711451	NONHSAT066590

No data

Variant related genes	Relation type
PSG4	TF binding region
CEACAMP11	TF binding region
ENSG00000227606	TF binding region
PSG5	TF binding region
CEACAMP10	TF binding region
PSG9	TF binding region
PSG4	CpG island
CEACAMP11	CpG island
ENSG00000227606	CpG island
PSG5	CpG island
CEACAMP10	CpG island
PSG9	CpG island
ENSG00000243137	chromatin interactions

Extended variants
information (count: 9186 )
Associated
traits (count: 73 )

Variant overlapped rSNPs/rCNVs (count:9186 , 50 per page) page: 1 2 3 4 5 6 7 ... 184

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs371950157	chr19:43614712-43614713	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs564873839	chr19:43614732-43614733	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs527238975	chr19:43614759-43614760	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs546998730	chr19:43614779-43614780	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs560815072	chr19:43614786-43614787	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs529958122	chr19:43614791-43614792	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs201064539	chr19:43614819-43614820	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs549700059	chr19:43614821-43614822	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs569824722	chr19:43614834-43614835	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs377399996	chr19:43614836-43614837	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs552594296	chr19:43614848-43614849	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs554421203	chr19:43614870-43614871	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs370490113	chr19:43614882-43614883	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs112666103	chr19:43614942-43614943	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs555027975	chr19:43614981-43614982	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs574916433	chr19:43614986-43614987	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs573086147	chr19:43615023-43615024	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs540532850	chr19:43615034-43615035	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs376903468	chr19:43615054-43615055	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs374753969	chr19:43615066-43615067	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs367640325	chr19:43615080-43615081	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs577362580	chr19:43615085-43615086	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs4029195	chr19:43615103-43615104	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs546081091	chr19:43615104-43615105	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs4029194	chr19:43615125-43615126	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs572061058	chr19:43615133-43615134	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs540595510	chr19:43615138-43615139	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs58522102	chr19:43615141-43615142	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs4029193	chr19:43615157-43615158	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs549663078	chr19:43615209-43615210	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs375833505	chr19:43615214-43615215	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs563439716	chr19:43615228-43615229	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs532293404	chr19:43615241-43615242	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs543965845	chr19:43615250-43615251	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs12459440	chr19:43615259-43615260	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs62112436	chr19:43615275-43615276	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs73934918	chr19:43615290-43615291	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs8102578	chr19:43615293-43615294	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs188999086	chr19:43615295-43615296	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs8102581	chr19:43615297-43615298	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs537487259	chr19:43615299-43615300	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs181678124	chr19:43615308-43615309	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs577477345	chr19:43615315-43615316	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs539988796	chr19:43615322-43615323	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs553311769	chr19:43615333-43615334	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs527951645	chr19:43615334-43615335	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs184766305	chr19:43615382-43615383	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs2354789	chr19:43615435-43615436	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs554292273	chr19:43615456-43615457	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs574048981	chr19:43615506-43615507	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:73)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Astrocytoma	22246337	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21509527	CNVD
Cancer	20164920	CNVD
Multiple myeloma	16616336	CNVD
Ovarian cancer	20800559	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Spondylocostal dysostosis	21085971	CNVD
Nicotine metabolism	21956041	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Glioblastoma multiforme	17002787	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17133270	CNVD
Hepatocellular carcinoma	16750200	CNVD
Colorectal cancer	20459617	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
early-passage human iPS cells	21368824	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD

Chromatin state (count:607 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:43609800-43615200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
2	chr19:43612200-43624200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
3	chr19:43614200-43614800	Enhancers	Muscle Satellite Cultured Cells	--
4	chr19:43614200-43614800	Enhancers	NHDF-Ad	bronchial
5	chr19:43614200-43615400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
6	chr19:43614200-43615400	Enhancers	NHEK	skin
7	chr19:43614400-43614800	Enhancers	NHLF	lung
8	chr19:43614400-43614800	Enhancers	Osteobl	bone
9	chr19:43614400-43615200	Enhancers	Hela-S3	cervix
10	chr19:43614400-43615400	Enhancers	HMEC	breast
11	chr19:43614600-43615200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
12	chr19:43615200-43615400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
13	chr19:43615200-43616600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
14	chr19:43615400-43623200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
15	chr19:43616600-43620400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
16	chr19:43620400-43621200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
17	chr19:43620600-43621000	Enhancers	Liver	Liver
18	chr19:43621000-43623200	Weak transcription	Liver	Liver
19	chr19:43621200-43623200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
20	chr19:43622800-43624800	Enhancers	NHEK	skin
21	chr19:43622800-43625000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
22	chr19:43623000-43624800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
23	chr19:43623000-43626800	Enhancers	HMEC	breast
24	chr19:43623200-43623600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
25	chr19:43623200-43624800	Enhancers	Hela-S3	cervix
26	chr19:43623200-43625200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
27	chr19:43623200-43625200	Enhancers	Liver	Liver
28	chr19:43623200-43625400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
29	chr19:43623200-43625400	Enhancers	Muscle Satellite Cultured Cells	--
30	chr19:43623400-43624800	Enhancers	Osteobl	bone
31	chr19:43623600-43625000	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
32	chr19:43623600-43625200	Enhancers	Breast Myoepithelial Primary Cells	Breast
33	chr19:43623600-43625200	Enhancers	NH-A	brain
34	chr19:43623600-43627000	Enhancers	NHDF-Ad	bronchial
35	chr19:43623800-43624000	Enhancers	Placenta	Placenta
36	chr19:43623800-43624600	Enhancers	A549	lung
37	chr19:43623800-43625200	Enhancers	HSMM	muscle
38	chr19:43623800-43625200	Enhancers	NHLF	lung
39	chr19:43624000-43628400	Weak transcription	Placenta	Placenta
40	chr19:43624200-43625200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
41	chr19:43624200-43625200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
42	chr19:43624400-43625000	Enhancers	Colon Smooth Muscle	Colon
43	chr19:43624600-43625200	Flanking Active TSS	A549	lung
44	chr19:43624800-43625200	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
45	chr19:43624800-43625200	Flanking Active TSS	Hela-S3	cervix
46	chr19:43624800-43625200	Enhancers	HSMMtube	muscle
47	chr19:43624800-43625200	Flanking Active TSS	NHEK	skin
48	chr19:43624800-43625200	Flanking Active TSS	Osteobl	bone
49	chr19:43624800-43625400	Enhancers	Cortex derived primary cultured neurospheres	brain
50	chr19:43624800-43626200	Enhancers	Brain Inferior Temporal Lobe	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links